tiprankstipranks
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
Holding BDRX?
Track your performance easily

Biodexa Pharmaceuticals (BDRX) Financial Statements

419 Followers

Biodexa Pharmaceuticals Financial Overview

Biodexa Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-49.738; its P/E ratio is -0.09; Biodexa Pharmaceuticals is scheduled to report earnings on April 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 6.42M£ 10.06M£ 4.20M£ 7.55M£ 4.33M
Total Assets£ 9.68M£ 12.91M£ 8.28M£ 9.82M£ 12.00M
Total Debt£ 713.00K£ 766.00K£ 812.00K£ 260.00K£ 3.51M
Net Debt£ -5.71M£ -9.29M£ -3.39M£ -7.29M£ -820.00K
Total Liabilities£ 2.19M£ 2.46M£ 4.52M£ 3.10M£ 7.45M
Stockholders Equity£ 7.49M£ 10.45M£ 3.75M£ 6.72M£ 4.55M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Biodexa Pharmaceuticals Earnings and Revenue History

Biodexa Pharmaceuticals Debt to Assets

Biodexa Pharmaceuticals Cash Flow

Biodexa Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis